Published by Sean Farrell on 14th September 2020
(Sharecast News) - N4 Pharma lost more than a third of its value after the company said its potential Covid-19 vaccine delivery method did not produce a positive result at stage 3 of tests.
URL: http://www.digitallook.com/dl/news/story/31170122/...